AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 50 filers reported holding AURA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,814 | -8.3% | 11,462 | +26.3% | 0.00% | – |
Q2 2023 | $112,089 | -21.4% | 9,076 | -40.9% | 0.00% | – |
Q1 2023 | $142,559 | +66.4% | 15,362 | +88.3% | 0.00% | – |
Q4 2022 | $85,670 | -41.3% | 8,159 | +1.5% | 0.00% | – |
Q3 2022 | $146,000 | +11.5% | 8,035 | -13.2% | 0.00% | – |
Q2 2022 | $131,000 | +101.5% | 9,261 | +213.9% | 0.00% | – |
Q1 2022 | $65,000 | +16.1% | 2,950 | -10.9% | 0.00% | – |
Q4 2021 | $56,000 | – | 3,310 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |